[Evidence-based therapy of irritable bowel syndrome. Intestine selective antibiotic relieves symptoms significantly].
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*; D008134:Long-Term Care; D016032:Randomized Controlled Trials as Topic; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin
D000890:Anti-Infective Agents; D012294:Rifamycins; D000078262:Rifaximin